obesity drug news today october 2025 glp-1 The first issue of New Scientist for 2026 brings a sharp focus on to weight loss medications. It suggests that weight-loss medications should get cheaper and more accessible (with expiry of Obesity GLP-1 Market

Potential improvements in fat content and glucose production might also occur in the liver as a result of GLP-1's impact [37]

This premier event, dedicated to supporting nutrition and dietetics professionals in Colorado, offered a valuable opportunity to share updated evidence on GLP-1 therapies, while also debunking common myths to promote informed and unbiased nutrition counseling

Most GLP-1 medications are peptides that are easily damaged by digestive enzymes and poorly absorbed in the gut

Patients receiving GLP-1RAs were on average younger than patients in the control group (54.6 vs 56.3 years)

Treatment Built Around You Dosing That Fits Your Journey Standard Protocol Compounded with high-quality ingredients through U.S.-certified, FDA-registered pharmacies